13th Annual CMHC

October 24-27, 2018

Boston, MA

The Cardiometabolic Event of the Year™

13th Annual Cardiometabolic Health Congress

October 24-27, 2018 - Boston, Massachusetts

Activity Title:

13th Annual Cardiometabolic Health Congress

Activity Date:

October 24-27, 2018 | Boston, Massachusetts

Target Audience

The CMHC is designed for advanced level clinicians responsible for the prevention, diagnosis, and management of cardiometabolic risk including cardiologists, endocrinologists, diabetologists, lipidologists, pharmacists, primary care clinicians (PCPs), nurse practitioners (NPs), physician assistants (PAs), and other allied health professionals.

Statement of Need/Program Overview

The ever-increasing presence of cardiometabolic risk continues to be a major challenge for health care providers in the United States. Current estimates suggest approximately 23% - 38% of all U.S. adults have metabolic syndrome, a constellation of cardiometabolic risk factors, including excessive abdominal fat, insulin resistance, inflammation, dyslipidemia, and hypertension. Patients with multiple cardiometabolic risk factors have twice the likelihood of developing and dying from cardiovascular disease and more than seven times the risk of developing diabetes compared to those with no cardiometabolic risk factors. Cardiovascular disease currently affects approximately 83.6 million U.S. adults (> 1 in 3) and is the leading cause of U.S. deaths; however, this CVD burden is expected to increase.

This sampling of sobering statistics points to a rapidly growing epidemic of cardiovascular and metabolic disease and calls to the forefront the need for medical education focused on all aspects of cardiometabolic risk. The Cardiometabolic Health Congress (CMHC) presents an especially valuable venue for this educational outreach bringing together faculty members from multiple disciplines, including cardiology, endocrinology, and primary care, to lead sessions that foster a collaborative, multidisciplinary approach to care.

The 2018 CMHC will translate the latest cutting edge medical research into practical, clinical strategies for preventing, delaying, diagnosing, treating, and managing cardiovascular and metabolic disorders. The goal is to provide the medical community with evidence based interventions that they can apply immediately in clinical practice to improve health outcomes and quality of life for the growing numbers of patients at increased cardiometabolic risk.

Educational Objectives

After completing this activity, the participant should be better able to:

  1. DEFINE the interrelationships among cardiometabolic risk factors, their impact on cardiovascular health, and their common comorbidities
  2. DESCRIBE evidence-based guideline recommendations based on recent clinical trials for prevention, screening, and treatment of cardiometabolic risk factors and their comorbidities
  3. OUTLINE strategies, including biomarkers, imaging, and lifestyle modifications, for the prevention and risk assessment of cardiometabolic disease
  4. IDENTIFY treatment regimens for cardiometabolic diseases based on efficacy and safety of current and new pharmacotherapies, and patient profiles and preferences to optimize patient outcomes
  5. DISCUSS recent clinical trial data for emerging treatment options for cardiometabolic diseases in order to stay current with the most recent updates in the cardiometabolic field
  6. CHOOSE communication strategies and patient education on new and emerging treatments, administration techniques, and technologies to implement into clinical practice in order to promote adherence to treatment regimens and provide patient-centered care

Faculty

Please click here to view all faculty listings.

Program Agenda

Please click here to view the full agenda.

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and CMHC. Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Global Education Group designates this live activity for a maximum of 27.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This educational activity for 27.75 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacotherapy hours will be included in this activity. Hours TBD.

Pharmacist Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation

Global Education Group designates this continuing education activity for 27.75 contact hour(s) (2.75 CEUs) of the Accreditation Council for Pharmacy Education. This is a knowledge based activity. Universal Activity Numbers (UAN) are listed below.

Session Title

UAN

Pre-Conference
"Women's Health Summit: Cardiometabolic Health Across the Lifespan"

Cardio-oncology: An emerging field

The Intersection Between Breast Cancer and Cardiovascular Disease

Interactive Participant Q&A Session

Cardiometabolic Risk in PCOS and Implications for Management

Impact of Pregnancy on CV Risk Factors and ASCVD Risk

Choosing Wisely: Contraception in Women with Cardiometabolic Risk

Updates on the Role of Postmenopausal Hormone Replacement Therapy

Women's Health Summit Expert Panel Discussion and Q&A

Session I: Diabetes Management

FDA Update and Late Breaking Trials

Keynote

So Many Options - Dispelling the Confusion About Insulins

Where are we with Devices for Diabetes Management?

How Many GLP1 RAs do We Need and Why?

Multidisciplinary Case Consults (Session I)

Session II: Obesity and Lifestyle Management in Cardiovascular Disease

Interventional Cardiology Delivered with a Fork

Updates on the Microbiome and Metabolic Surgery

Obesity and Environmental Influence: The Big Picture

Day to Day Management of Obesity in Clinical Practice

CME LUNCH: Identifying, Diagnosing and Managing Iron Deficiency in Patients with Heart Failure to Improve Outcomes and Quality of Life

Session III: Dyslipidemia, Atherosclerosis, and Cardiovascular Disease Risk Reduction

Targeting Inflammation: Updates on Pathophysiology and Clinical Outcomes

How Aggressively do we Lower LDL-C and for Which Patients?

Risk Assessment for Global Cardiovascular Disease: Imaging and Biomarkers

Multidisciplinary Case Consults (Session III)

Session IV: Hypertension, Cardio-renal, and Heart Failure

Overview of the New 2017 Hypertension Clinical Practice Guidelines

Comparing the Hypertension Guidelines - Where is the Equipoise?

Patient Cases: How would you change the management of hypertension based on the new guidelines?

Prevention of Heart Failure: The Next Frontier

Integration of Biomarkers and Prediction of AKI and Cardio-renal Outcomes in Clinical Practice

AKI and Heart Failure: How to manage compared to general population?

Advanced CKD and Benefits from CVOTs

Dietician Accreditation Statement

Global Education Group is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). CDR Credentialed Practitioners will receive 27.75 Continuing Professional Education units (CPEUs) for completion of this activities / materials.
CPE Provider #GE012

Global Contact Information

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Instructions to Receive Credit

In order to receive credit for this activity, the participant must complete the CMHC Program Evaluation. A link to the online evaluation will be emailed to all participants by approximately Monday, October 29, 2018. Online evaluations must be completed by November 19, 2018. CME/CE Certificates will be available for print immediately upon completion of the online evaluation form.

Pharmacists Only: In order to receive credit, the ACPE requires that you provide your NABP ePID (6-10 digits) along with month and date of birth (MM/DD) in the online evaluation. After completion of the evaluation via steps outlined above, record of your participation will be uploaded to the CPE Monitor under your NABP e-profile within 60 days. You may print an individual statement of credit for this activity from your NABP e-profile. CMHC strongly encourages you to check your e-profile to ensure your credit is appropriately claimed before December 23, 2018.

Fee Information & Refund/Cancellation Policy

There is registration fee for this educational activity, registration information can be found here.

Disclosure of Conflicts of Interest

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Planner or Manager

Reported Financial Relationship

Ashley Marostica, RN, MSN

Nothing to disclose

Lindsay Borvansky

Nothing to disclose

Andrea Funk

Nothing to disclose

Amanda Turner

Nothing to disclose

Liddy Knight

Nothing to disclose

Erin Franceschini, MS

Nothing to disclose

Amanda Jamrogiewicz

Nothing to disclose

Karin McAdams

Nothing to disclose

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and CMHC do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Educational Grant Support

The 13th Annual CMHC is supported in part by an independent and unrestricted educational grant from Akcea Therapeutics, Amarin Pharma Inc., Novartis Pharmaceuticals Corporation, and Novo Nordisk. Please continue to check this page for updates.

For educational symposia support please visit this page.

This activity is jointly provided by Global Education Group and Tarsus Cardio Inc. dba Cardiometabolic Health Congress.